Retraction Note: β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.

Saved in:
Bibliographic Details
Title: Retraction Note: β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
Authors: Huang Z; Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Department of Anesthesiology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, 350001, China., Li G; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Zhang Z; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Gu R; Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Wang W; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Lai X; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Cui ZK; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China., Zeng F; Department of Clinical Laboratory, the Fifth Affiliated Hospital, Southern Medical University, Guangzhou, 510900, China. zengfy@126.com., Xu S; Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. xsy998@smu.edu.cn., Deng F; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. fandeng@smu.edu.cn.
Source: BMC cancer [BMC Cancer] 2025 Mar 14; Vol. 25 (1), pp. 475. Date of Electronic Publication: 2025 Mar 14.
Publication Type: Journal Article; Retraction Notice
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-025-13878-7